Taurine - 2 Aminoethane 1 sulfonic acid

Taurine – Regulator of cellular function

by | Jun 15, 2021 | Blog, Cardiometabolic disease, Metabolite of the month, Neurology

History and Evolution

1827: first isolated in ox bile | 1846: first discovery in human bile

Taurine is an aminosulfonic acid with high intracellular concentrations in the brain, retina, heart, skeletal muscles, and leukocytes in humans (Bayarmaa et al., 2013; Lourenço et al., 2002). It was first isolated from ox bile in 1827 by two German scientists, Friedrich Tiedemann and Leopold Gmelin (Tiedemann et al., 1827). Referencing this, taurine gets its name from the Latin taurus, meaning bull or ox.

Over the following decades, studies revealed the presence of taurine in animal bile and muscle tissue, including human bile in 1846 (Ronalds et al., 2019). Taurine does not appear to be present to the same degree in plants (Jacobsen et al., 1968; Hou et al., 2019).

Taurine is considered a “conditionally” essential amino acid, due to its lack of involvement in protein synthesis. However, given its significant role in many biological processes including bile salt formation, osmoregulation, antioxidation, retinal development, and the central nervous and cardiovascular systems, its presence in the body appears very much essential (Ripps et al., 2012; Stapleton et al., 1998).

Biosynthesis vs. dietary uptake

Taurine is derived from the conditionally essential amino acid, cysteine, which is a product of methionine catabolism. Unlike other amino acids, taurine contains a sulfide group instead of a carboxyl group, which makes it an amino sulfonic acid. Taurine is synthesized in humans in the liver via two pathways:

  • in the cysteine sulfinic pathway, cysteine is oxidized to cysteine sulfinic acid by the enzyme cysteine dioxygenase. It is then decarboxylated by cysteine sulfinic acid decarboxylase (CSAD) to form hypotaurine. Hypotaurine is oxidized by hypotaurine dioxygenase to form taurine (Ripps et al., 2012).
  • in the transsulfuration pathway, homocysteine is converted into cystathionine. This is converted into hypotaurine with assistance from several enzymes, and then oxidized to form taurine.

Most taurine is obtained through diet and absorbed in the small intestine. It is transported to the liver and released into the blood stream, then enters cells throughout the body via the taurine transporter (TauT). Excess taurine is excreted through urine or conjugated to bile acids.

Meat and fish are good sources of taurine, and a diet containing animal products usually contains sufficient taurine for physiological needs. People following vegetarian or vegan diets have been shown to have lower levels of taurine in plasma (Laidlaw et al., 1988). Because of taurine’s role in retinal and brain development, children who consume diets low in animal protein may need to supplement their taurine intake (Wójcik et al., 2010).

Premature infants are vulnerable to taurine deficiency because they lack the enzymes needed to synthesize cysteine. Human breast milk contains high levels of taurine which is sufficient for newborns. Formula milk is often supplemented with taurine, though evidence is mixed as to whether this is beneficial or not (Chawla et al., 2018).

Taurine is a common ingredient in energy drinks, though since many of these also include high levels of caffeine, it’s not clear whether any perceived energy boost is attributable to taurine.

Taurine as a regulator of cellular function

Taurine’s role varies according to cell type (Stapleton et al., 1998). In the central nervous system, taurine functions as an intracellular osmolyte, regulating cell volume and stabilizing cell membranes, and its presence is important for optimal cell development in the brain, retina, skeletal muscle, and other organs (Stapleton et al., 1998). Deficiency is associated with cardiomyopathy, renal and pancreatic dysfunction, retinal damage, and diabetes.

Taurine also acts as an antioxidant: concentration is particularly high in cells exposed to oxidative stress, and deficiency is linked with cell death (Jong et al., 2013). However, taurine is not a scavenger of free radicals, and the precise mechanism of antioxidant action is unclear. One known process involves a toxicity-suppressing reaction with halogenating agents such as hypochlorous acid, but taurine has demonstrated a protective effect in cells where these agents are absent (Marcinkiewicz et al., 2014). While there is no confirmed link between taurine deficiency and immunodeficiency, its broad cytoprotective properties suggest therapeutic potential (Marcinkiewicz et al., 2014; Schaffer et al., 2018).

Taurine, bile salts and microbiota

Taurine’s main function is the conjugation of cholesterol into bile acids. Bile acids are conjugated with taurine or glycine at a ratio of about 1:3, to form bile salts, which in turn form mixed micelles with phospholipids and cholesterol (Chiang, 2013). These are stored in the gallbladder and secreted to ease digestion and nutrient absorption.

Studies show links between a high fat diet, increased taurine conjugation and bile pool size and composition. Bilophila, a bacterium that thrives in bile, has been shown to use the sulfite in taurine as a terminal electron acceptor, allowing it to proliferate in the gut (Ridlon et al., 2014). This also helps to explain the link between diets high in red meat and increased risk of colorectal cancer. When gut microbes metabolize taurine-conjugated bile acids, hydrogen sulfide and deoxycholic are produced, which are both associated with tumor growth in the colon (Ridlon et al., 2014).

However, taurine has also been shown to have a protective effect on the microbiome, which could help address over-reliance on antibiotics. One study found that taurine levels influence pathogen colonization in the gut, and that a mild infection can prompt the liver and gallbladder to draw on taurine-conjugated bile acids to strengthen the microbiome and promote resistance to further infection (Stacy et al., 2021). This has exciting implications for microbiota-based therapeutics.

Taurine and neurobiology

Taurine is found in high levels in the brain. It plays a major role in brain development, including neuronal and stem cell proliferation (Li X.W. et al., 2017). These levels seem to decrease with age, prompting investigation of taurine’s relationship to neurodegenerative diseases such as Alzheimer’s, Huntington’s, and Parkinson’s (Schaffer et al., 2018).

Disruptions in taurine homeostasis have also been linked to neurological conditions including epilepsy and autism. As a membrane stabilizer, taurine appears to modulate hyper reactivity of cells in epilepsy. Isothionic acid, a metabolite of taurine, is linked with more frequent seizures (Kothandam, 2012). Taurine stimulates GABA receptors, which increase inhibitory actions in the limbic system, and are shown to reduce susceptibility to seizures in rodent models (El Idrissi A. et al., 2003).

Emerging findings suggest a link between the gut-brain axis and autism spectrum disorder. A study of human subjects using a novel mass spectrometry metabolomic profiling method found that individuals with ASD had consistently high levels of taurine in plasma, suggesting its potential as a biomarker for ASD (Kuwabara et al., 2013).

Taurine is also attracting increasing interest as a potential therapeutic agent for ischemic stroke. The main mechanisms involved ischemic stroke are glutamate excitoxicity, calcium imbalance and oxidative stress. As an antioxidant and inhibitory neurotransmitter, taurine has been shown to protect against these mechanisms in rodent models (Menzie et al., 2013). In human studies, taurine therapy has been shown to mitigate the impaired formation of taurine conjugate in mitochondrial disease, mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) (Rikimaru M. et al., 2012; Schaffer et al., 2018).

Taurine and diabetes

Taurine’s role in the prevention, development and treatment of diabetes has been widely studied. Evidence suggests taurine supplementation can be effective against type 1 diabetes, type 2 diabetes mellitus and metabolic syndrome, as well as some common diabetic complications (Ito T. et al., 2012). However, most studies have been conducted in rodent models, and more research is needed to understand the therapeutic effect of taurine in chronic diabetes.

Taurine and renal dysfunction

Taurine has been shown to influence several types of kidney disease, including renal failure, acute kidney injury, glomerulonephritis, and diabetic nephropathy. As with diabetes, most investigations have been conducted on animal models, but taurine’s confirmed role in regulating blood flow, cell volume, and oxidative stress suggests a protective effect (Chesney et al., 2010).

Taurine and the eyes

The retina is the most taurine-rich organ in the body, containing more taurine than any other amino acid (Castelli et al., 2021). Oxidative stress is a major cause of retinal degenerative diseases, which makes taurine a therapeutic candidate. The discovery that the anti-epileptic drug, vigabatrin, caused retinal degeneration and taurine deficiency prompted investigation of the links between taurine and retinal disease. Low levels of taurine in plasma of diabetic patients have been linked to diabetic retinopathy (Froger et al., 2014).

Learn more about the roles of taurine and conjugated bile acids in complex chronic diseases such as cancer, Alzheimer’s disease, depression, inflammatory bowel disease, multiple sclerosis and diabetes in our whitepaper “Complex chronic diseases have a common origin”.



Bayarmaa, B. et al.:Synthesis and characterization of Taurine. (2013) Mongolian Journal of Chemistry | https://doi.org/10.5564/mjc.v14i0.200

Castelli, V. et al.: Taurine and oxidative stress in retinal health and disease. (2021) CNS Neuroscience and Therapeutics | https://doi.org/10.1111/cns.13610

Chawla, D. et al.: Taurine and Neonatal Nutrition. (2018) Indian Journal of Pediatrics | https://doi.org/10.1007/s12098-018-2781-2

Chesney, R. et al.: Taurine and the renal system.(2010) Journal of Biomedical Science | https://doi.org/10.1186/1423-0127-17-S1-S4

Chiang, J.: Bile Acid Metabolism and Signaling. (2013) Comprehensive Physiology | https://doi.org/10.1002/cphy.c120023

El Idrissi, A., et al.: Prevention of Epileptic Seizures by Taurine. (2003) Advances in Experimental Medicine and Biology | https://doi.org/10.1007/978-1-4615-0077-3_62

Froger, N. et al.: Taurine: the comeback of a neutraceutical in the prevention of retinal degenerations. (2014) Prog Retin Eye Res. | https://doi.org/10.1016/j.preteyeres.2014.03.001

Hou, Y. et al.: Composition of polyamines and amino acids in plant-source foods for human consumption. (2019) Amino Acids | https://doi.org/10.1007/s00726-019-02751-0

Ito, T. et al.: The potential usefulness of taurine on diabetes mellitus and its complications. (2012) Amino Acids | https://doi.org/10.1007/s00726-011-0883-5

Jacobsen, J. et al.: Biochemistry and physiology of taurine and taurine derivatives. (1968) Physiological Reviews | https://doi.org/10.1152/physrev.1968.48.2.424

Jong, C. et al.: Mechanism underlying the antioxidant activity of taurine. (2013) Experimental Biology 2013 Meeting Abstracts | https://doi.org/10.1096/fasebj.27.1_supplement.1086.1

Kothandam, H. et al.: TAURINE, “A Key Amino Acid in the Drug Discovery” – A Review. (2012) Asian Journal of Biomedical and Pharmaceutical Sciences | https://www.alliedacademies.org/abstract/taurine

Kuwabara, H. et al.: Altered Metabolites in the Plasma of Autism Spectrum Disorder: A Capillary Electrophoresis Time-of-Flight Mass Spectroscopy Study. (2013) PLOS One | https://doi.org/10.1371/journal.pone.0073814

Laidlaw, S. et al.: Plasma and urine taurine levels in vegans. (1988) American Journal of Clinical Nutrition | https://doi.org/10.1093/ajcn/47.4.660

Li, X.W. et al.: The role of taurine in improving neural stem cells proliferation and differentiation. (2017) Nutritional Neuroscience | https://doi.org/10.1080/1028415x.2016.1152004

Lourenço, M. et al.: Taurine: a conditionally essential amino acid in humans? An overview in health and disease. (2002) Nutrición Hospitalaria, | https://pubmed.ncbi.nlm.nih.gov/12514918/

Marcinkiewicz, J. et al.: Taurine and inflammatory diseases. (2014) Amino Acids | https://doi.org/10.1007/s00726-012-1361-4

Menzie, J. et al.: Neuroprotective Mechanisms of Taurine against Ischemic Stroke. (2013) Brain Sciences | https://doi.org/10.3390/brainsci3020877

Ridlon, J. et al.: Bile Acids and the Gut Microbiome. (2014) Gastroenterology | https://doi.org/10.1097/MOG.0000000000000057

Rikimaru M., et al.: Taurine ameliorates impaired the mitochondrial function and prevents stroke-like episodes in patients with MELAS. (2012) Internal Medicine | https://doi.org/10.2169/internalmedicine.51.7529

Ripps, H.: Review: Taurine: A “very essential” amino acid. (2012) Molecular Vision, | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3501277/

Ronalds, B. et al.: Bringing Together Academic and Industrial Chemistry: Edmund Ronalds’ Contribution. (2019) Substantia | https://doi.org/10.13128/Substantia-211

Schaffer, S. et al.: Effects and Mechanisms of Taurine as a Therapeutic Agent. (2018) Biomol Ther | https://doi.org/10.4062/biomolther.2017.251

Schuller-Levis, G. et al.: Is Taurine A Biomarker? (2006) Advances in Clinical Chemistry | https://doi.org/10.1016/S0065-2423(05)41001-X

Stacy, A. et al.: Infection trains the host for microbiota-enhanced resistance to pathogens. (2021) Cell | https://doi.org/10.1016/j.cell.2020.12.011

Stapleton, P. et al.: Review: Host Defense-A Role for the Amino Acid Taurine? (1998) Journal of Parenteral and Enteral Nutrition | https://doi.org/10.1177/014860719802200142

Tiedemann, F. et al.: Einige neue Bestandtheile der Galle des Ochsen. (1827) Annalen der Physik | https://doi.org/10.1002/andp.18270850214

Wójcik, O. et al.: The potential protective effects of taurine on coronary heart disease. (2010) Atherosclerosis | https://doi.org/10.1016/j.atherosclerosis